Protoxin
FDA Label NDC 71066-0001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Protox Inc. for the product Protoxin (NDC 71066-0001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, warnings, dosage & administration, indications & usage, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Clostridium botulinum Toxin Type A

Inactive Ingredient

Normal human serum albumin, Sodium chloride

Otc - Purpose

Stop a secretion of the neurotransmitter acetylcholine in a place to see nerves and muscles.
Lessening the rigidity of the child with cerebral palsy using the qualities that lead to muscle paralysis.

Warnings

Confirm the validity of the product label

to make sure the sterilizatios is not damaged before using

Dosage & Administration

N/A

Package Label.Principal Display Panel

Product Label (Label)

Product Label (Label)

* Please review the disclaimer below.